Alzheimer’s Drug Discovery Foundation-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Alzheimer's Drug Discovery Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011851
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Alzheimer’s Drug Discovery Foundation (ADDF), formerly Institute for the Study of Aging is a drug discovery foundation that offers funds for drug discovery and development research programs in the field of Alzheimer’s disease, related dementias and cognitive aging. The foundation offers services and support for development of drugs to prevent, treat, and cure Alzheimer’s disease. It offers grants to the recipients for the treatment of Alzheimer’s disease. The foundation offers funds on preclinical research and early-stage clinical trials for new drug targets. It partners with various universities, and other research and development organizations. ADDF is headquartered in New York, the US.

Alzheimer’s Drug Discovery Foundation – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Alzheimer’s Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Alzheimer’s Drug Discovery Foundation, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Alzheimer’s Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Alzheimer’s Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Alzheimer’s Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Alzheimer’s Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
M3 Biotechnology Raises USD15.2 Million in Venture Financing 10
M3 Biotech Raises USD1.4 Million in Second Round of Venture Financing 12
Partnerships 13
Alzheimer Drug Discovery Enters into Research Agreement with CTI for Alzheimer’s Disease Drugs 13
Equity Offering 14
Oryzon Genomics Raises USD0.7 Million in Private Placement of Shares upon Exercise of Warrants 14
Alzheimer’s Drug Discovery Foundation – Key Competitors 15
Alzheimer’s Drug Discovery Foundation – Key Employees 16
Alzheimer’s Drug Discovery Foundation – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Government and Public Interest 18
Apr 20, 2017: ADDF-Funded Scientists Discover Two Repurposed Drugs With Promise for Alzheimers and FTD 18
Mar 01, 2017: Cypralis Announces Grant Award from Alzheimer’s Drug Discovery Foundation 19
Product News 20
Jun 07, 2017: The Alzheimer’s Drug Discovery Foundation and Science Exchange Launch ADDF ACCESS to Advance CNS Research 20
Other Significant Developments 21
Jun 07, 2017: ADDF and Science Exchange Launch ADDF ACCESS to Advance Research 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Key Facts 2
Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Alzheimer's Drug Discovery Foundation, Deals By Therapy Area, 2011 to YTD 2017 8
Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
M3 Biotechnology Raises USD15.2 Million in Venture Financing 10
M3 Biotech Raises USD1.4 Million in Second Round of Venture Financing 12
Alzheimer Drug Discovery Enters into Research Agreement with CTI for Alzheimer's Disease Drugs 13
Oryzon Genomics Raises USD0.7 Million in Private Placement of Shares upon Exercise of Warrants 14
Alzheimer's Drug Discovery Foundation, Key Competitors 15
Alzheimer's Drug Discovery Foundation, Key Employees 16

★海外企業調査レポート[Alzheimer’s Drug Discovery Foundation-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sparton Resources Inc (SRI):企業の財務・戦略的SWOT分析
    Summary Sparton Resources Inc (Sparton Resources) is a diversified company that acquires and develops oil and gas properties in North America and China. The company’s products include vanadium, natural gas, crude oil, gold, and vanadium flow batteries, among others. Its energy projects comprise Sier …
  • Tecomet Inc:医療機器:M&Aディール及び事業提携情報
    Summary Tecomet Inc (Tecomet) is a medical equipment company that manufactures and markets cases, implants and instruments. The company offers various implants which include acetabular cups, femoral heads, femoral stems, poly liners, femoral wraps, patellas, poly inserts, tibia trays, hooks, plates, …
  • Hydro-Quebec:企業の戦略的SWOT分析
    Hydro-Quebec - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Mega Corporation Ltd
    Mega Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary Mega Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Deltex Medical Group Plc (DEMG):企業の財務・戦略的SWOT分析
    Summary Deltex Medical Group Plc (Deltex Medical), formerly Chalkgrove Plc, is a medical device company that develops fluid management equipment and oesophageal doppler monitoring systems. The company offers products such as cardioQ-ODM+, probes, simulator, bougies, cerebral oximetry, video laryngos …
  • Greggs Plc:企業の戦略・SWOT・財務情報
    Greggs Plc - Strategy, SWOT and Corporate Finance Report Summary Greggs Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • DIC Corp (4631):企業の財務・戦略的SWOT分析
    DIC Corp (4631) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Agappe Diagnostics Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Agappe Diagnostics Ltd (Agappe) is an in vitro diagnostic company that manufactures clinical chemistry and immuno turbidimetry products. The company’s products categories include biochemistry, immunochemistry, serology, coagulation, hematology, system reagents, controls and calibrators; poin …
  • Saras SpA (SRS):石油・ガス:M&Aディール及び事業提携情報
    Summary Saras SpA (Saras) is crude oil refiner and operates refining, marketing, power generation and wind power businesses. The company’s major refinery is Sarroch refinery, on the Southwestern coast of Sardinia. Saras is also active in the production and sale of electricity, and offers industrial …
  • Tullow Oil plc:企業の戦略・SWOT・財務分析
    Tullow Oil plc - Strategy, SWOT and Corporate Finance Report Summary Tullow Oil plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • ZyGEM NZ Ltd:医療機器:M&Aディール及び事業提携情報
    Summary ZyGEM NZ Ltd (ZyGEM), a subsidiary of MicroGEM International PLC is a drug development company that develops and technologies for life science, agricultural and horticultural industries. The company produces DNA extraction products, and enzymes used in diagnostics, molecular biology and indu …
  • CompuGroup Medical SE:企業のM&A・事業提携・投資動向
    CompuGroup Medical SE - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CompuGroup Medical SE Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Dabur India Limited:戦略・SWOT・企業財務分析
    Dabur India Limited - Strategy, SWOT and Corporate Finance Report Summary Dabur India Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Trustpower Ltd:企業の戦略的SWOT分析
    Trustpower Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Envipco Holding NV (ENVI):企業の財務・戦略的SWOT分析
    Envipco Holding NV (ENVI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Sensile Medical AG:医療機器:M&Aディール及び事業提携情報
    Summary Sensile Medical AG (Sensile) is a medical device company that develops and produces key technologies for liquid drug delivery devices. The company develops products in the areas of micro insulin delivery and glucose monitoring systems. Its pipeline products comprise sensepatch and senseflex. …
  • Nachi-Fujikoshi Corp.:企業の戦略・SWOT・財務分析
    Nachi-Fujikoshi Corp. - Strategy, SWOT and Corporate Finance Report Summary Nachi-Fujikoshi Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Tetra Technologies, Inc.:企業の戦略・SWOT・財務分析
    Tetra Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tetra Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Just the Berries Ltd:企業の戦略・SWOT・財務情報
    Just the Berries Ltd - Strategy, SWOT and Corporate Finance Report Summary Just the Berries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Nido Petroleum Limited:石油・ガス:M&Aディール及び事業提携情報
    Summary Nido Petroleum Limited (Nido), a subsidiary of BCP Energy International Pte. Ltd, is an upstream energy company. It explores for, develops, and produces oil and gas. Nido holds working interests in exploration permits in the North West Palawan basin of the Philippines. The company operates t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆